VISMODEGIB is a Schedule H drug.
Tag: medicine for basal cell carcinoma
QMICA 5% CRM
QMICA 5% CRM is a Schedule H drug. QMICA 5% CRM is composed of: IMIQUIMOD (5.0 %)
NILWART 5% W/W CRM
NILWART 5% W/W CRM is a Schedule H drug. NILWART 5% W/W CRM is composed of: IMIQUIMOD (5.0 %W/W)
IMIQUAD 12.5MG CRM
IMIQUAD 12.5MG CRM is a Schedule H drug. IMIQUAD 12.5MG CRM is composed of: IMIQUIMOD (12.5 MG)
IMIQUIMOD
IMIQUIMOD is a Schedule H drug.